已发生的网络研讨会
获取有关我们最新活动和网络研讨会的最新消息。
This webinar will review the implications of ILD toxicity monitoring in ADC trials. Dr. Sood will present best practices for using HRCT for the detection and characterization of ILD.
Topics Covered: Medical Imaging
Medication supply shortages have become a widespread industry concern. However, a considered RTSM design can prevent shortages from jeopardizing your study goals.
Topics Covered: IRT
In this webinar, Professor Fendler from the University of Essen and Calyx’s Dr. Oliver Bohnsack will address these challenges and provide recommendations on how to overcome them based on their own lessons learned from conducting prostate cancer trials.
Topics Covered: Medical Imaging
Watch a quick demo of Calyx product on demand
目前,客观生物标志物的缺乏给开发精神和神经疾病治疗方法的研究人员带来了巨大的挑战。But now, a partnership that combines Calyx’s clinical trial imaging expertise and Ceretype’s novel functional MRI (fMRI) platform enables trial sponsors to overcome this challenge and see the physical action of a drug on patients with psychiatric and other neurological disorders.
Topics Covered: 医学影像
This session will focus on the difficulty of evaluating HCC patient scans after local intervention and how sponsors can overcome the complexities associated with imaging in HCC clinical trials.
Topics Covered: 医学影像
In this webinar, Calyx’s Peter Tarbox shares the RTSM factors oncology trial sponsors should consider in their IRT design, focusing on how advanced IRT systems can accommodate changes in centrally and locally sourced medication for optimal clinical trial supply management.
Topics Covered: IRT
In this webinar, Calyx’s Malcolm Morrissey and Maarit Kelvin Korpos review other scenarios of how study data can lead to unintentional unblinding and the processes sponsors and their IRT solution providers should follow to mitigate these risks.
Topics Covered: IRT
Get a glimpse into what it’s like to work with Calyx Medical Imaging and how our professional client delivery teams deliver optimal imaging solutions that meet your study needs.
Topics Covered: 医学影像
This scientific discussion will review how emerging AI solutions that employ quantitative neuroimaging can help address some of the key challenges faced in Alzheimer’s Disease.
Topics Covered: Medical Imaging
In this webinar, Calyx’s Head of Statistics and Product Support Services, Malcolm Morrissey shares his experience on how to identify the randomization implementation options that can lead to unblinding of the block size and other potential risks that could result in selection bias at the site.
Topics Covered: IRT
Learn how the functions and features of Calyx IRT get the right treatment to the right patient at the right time, regardless of how complex your RTSM needs are.
Topics Covered: IRT
In this webinar, Dr. Oliver Bohnsack of Calyx – a leading expert on RECIST and irRECIST – discusses the implications of these findings, what it means for oncology clinical development and treatment decision-making, and why irRECIST easily can and shall replace outdated RECIST 1.1 on all solid tumor trials going forward.
Topics Covered: IRT
A panel of clinical trial sponsor and distribution partner representatives – all with experience in direct-to-patient shipments – will review what is possible to achieve and what constraints may be encountered when considering DtP for clinical trials. We’ll also hear from the most important clinical trial stakeholder, a patient who has experienced the shift from in-clinic visits to treatment delivered at their doorstep; he will share his perspective as it relates to the development of a DtP clinical trial strategy.
Topics Covered: DtP
Topics Covered: DtP
In this live virtual event, a panel of key opinion leaders including IMWG 2016 authors and imaging experts will answer your questions about the changing landscape of imaging in multiple myeloma trials and how to optimize imaging-related assessments.
Topics Covered: 医学影像
在此次网络研讨会中,我们回顾如何通过应用先进的 IRT 设置来控制供应链,如何将药物准确发送到招募研究中心,以及如何尽量减少运送到这些研究中心的数量,从而在总体上限制研究中心浪费的药物数量。
Topics Covered: IRT
Join Calyx’s Head of Statistics and Product Support Services, Malcolm Morrissey, for a webinar focusing on an undervalued aspect of study and IRT design.
Topics Covered: IRT
Medication supply shortages have become a widespread industry concern. However, a considered RTSM design can prevent shortages from jeopardizing your study goals.
Topics Covered: IRT
In this webinar, Professor Fendler from the University of Essen and Calyx’s Dr. Oliver Bohnsack will address these challenges and provide recommendations on how to overcome them based on their own lessons learned from conducting prostate cancer trials.
Topics Covered: Medical Imaging
目前,客观生物标志物的缺乏给开发精神和神经疾病治疗方法的研究人员带来了巨大的挑战。But now, a partnership that combines Calyx’s clinical trial imaging expertise and Ceretype’s novel functional MRI (fMRI) platform enables trial sponsors to overcome this challenge and see the physical action of a drug on patients with psychiatric and other neurological disorders.
Topics Covered: 医学影像
This session will focus on the difficulty of evaluating HCC patient scans after local intervention and how sponsors can overcome the complexities associated with imaging in HCC clinical trials.
Topics Covered: 医学影像
In this webinar, Calyx’s Peter Tarbox shares the RTSM factors oncology trial sponsors should consider in their IRT design, focusing on how advanced IRT systems can accommodate changes in centrally and locally sourced medication for optimal clinical trial supply management.
Topics Covered: IRT
In this webinar, Calyx’s Malcolm Morrissey and Maarit Kelvin Korpos review other scenarios of how study data can lead to unintentional unblinding and the processes sponsors and their IRT solution providers should follow to mitigate these risks.
Topics Covered: IRT
Get a glimpse into what it’s like to work with Calyx IRT and how we customize our configurable core IRT system to meet your specific study needs.
Topics Covered: IRT
This scientific discussion will review how emerging AI solutions that employ quantitative neuroimaging can help address some of the key challenges faced in Alzheimer’s Disease.
Topics Covered: Medical Imaging
In this webinar, Calyx’s Head of Statistics and Product Support Services, Malcolm Morrissey shares his experience on how to identify the randomization implementation options that can lead to unblinding of the block size and other potential risks that could result in selection bias at the site.
Topics Covered: IRT
In this webinar, Dr. Oliver Bohnsack of Calyx – a leading expert on RECIST and irRECIST – discusses the implications of these findings, what it means for oncology clinical development and treatment decision-making, and why irRECIST easily can and shall replace outdated RECIST 1.1 on all solid tumor trials going forward.
Topics Covered: IRT
A panel of clinical trial sponsor and distribution partner representatives – all with experience in direct-to-patient shipments – will review what is possible to achieve and what constraints may be encountered when considering DtP for clinical trials. We’ll also hear from the most important clinical trial stakeholder, a patient who has experienced the shift from in-clinic visits to treatment delivered at their doorstep; he will share his perspective as it relates to the development of a DtP clinical trial strategy.
Topics Covered: DtP
Topics Covered: DtP
In this live virtual event, a panel of key opinion leaders including IMWG 2016 authors and imaging experts will answer your questions about the changing landscape of imaging in multiple myeloma trials and how to optimize imaging-related assessments.
Topics Covered: 医学影像
在此次网络研讨会中,我们回顾如何通过应用先进的 IRT 设置来控制供应链,如何将药物准确发送到招募研究中心,以及如何尽量减少运送到这些研究中心的数量,从而在总体上限制研究中心浪费的药物数量。
Topics Covered: IRT
Join Calyx’s Head of Statistics and Product Support Services, Malcolm Morrissey, for a webinar focusing on an undervalued aspect of study and IRT design.
Topics Covered: IRT
收件人: 凯理斯
发件人: 前五大制药公司
主题: Calyx 医学成像有助于快速治疗患者
非常感谢 Calyx Medical Imaging 在周转时间线之外开展工作,以审查最终允许中心团队批准入组的扫描,从而尽快促进该患者的治疗。这是对我们价值观的真正证明,确保我们尽快为有需要的患者接受治疗。
收件人: 凯理斯
发件人: 前五大制药公司
主题: Calyx Medical Imaging 批准成为可能
非常感谢 Calyx 医学影像团队。项目获批的荣耀也属于你们,你们应该为自己所做的工作感到自豪。期待未来更多的项目获得批准!
– 全球试验经理
肝癌开发项目
收件人: 凯理斯
发件人: Veralox 餐厅
受试者: Calyx 医学成像 – 感谢您满足严格的时间表
Calyx Medical Imaging 团队给我留下了深刻的印象,他们在帮助我们推进项目的过程中提供了令人难以置信的合作。我们特别感谢团队在紧迫的时间表上努力帮助我们实现研究启动目标。鉴于我们是一家小公司,我们依靠我们的合作者,Calyx 的团队在我们身边无缝工作,帮助我们推进发展计划。我期待继续我们的合作关系!
– Alicia Herr,PMP,
Veralox Therapeutics
收件人: 凯理斯
发件人: 前五大制药公司
主题: Calyx 医学成像 – 透明、持续协作
我们在关键性子宫肌瘤研究中与 Calyx 密切合作。成功的关键组成部分包括我们的研究团队和 Calyx 之间透明的持续协作,以及各级的实时沟通。在整个研究过程中,这种沟通有助于确保我们的团队获得及时做出明智决策和交付交付物质量数据所需的信息。我们能够从先前的研究中获得经验教训,并实施这项研究的经验教训。我期待着继续共同努力,努力为女性提供更多的治疗选择。
收件人: 凯理斯
发件人: 抵达
主题: 全球肿瘤学计划 – Calyx 医学成像头肩关节高于其他部位
我写信是为了向 Calyx 提供的专家独立中心影像审查服务作证,以支持 ArriVent 的两项全球临床肿瘤学研究。Calyx 在各种肿瘤疗效标准、影像模态、影像运营、数据管理和支持监管审查方面拥有深厚的技术专长。他们在方案和章程制定过程中为 ArriVent 提供了宝贵的建议。再加上由世界一流的高度专业化的独立放射科医生、影像科学家、项目经理、医学写作、高效的预算和合同小组以及一流的内部流程和系统组成的团队,所有这些都为我们重要管线项目的顺利启动项目做出了贡献。
我们采访了许多不同的影像 CRO,Calyx 肯定是头肩背靠其他影像。
– Morgan Lam
开发运营和业务管理高级副总裁,
Arrivent Biopharma
收件人: 凯理斯
发件人: 前 3 大制药公司
主题: 谢谢 Calyx 医学成像 – 骨质疏松症试验成功
我非常感谢 Calyx 团队对这一出色研究结果的贡献。没有你,这种上市许可将永远不可能。
-医学负责人,骨质疏松症试验,
前 3 大制药公司
收件人: 凯理斯
发件人: ProTrials 试验
主题: 很高兴与 Calyx 合作
我们很高兴与Calyx合作,并相信我们的客户将受益于30年中积累的科学、医学和临床专业知识。
– Christy Meyer
质量保险总监,
收件人: 凯理斯
发件人: LG 化学
主题: Calyx IRT – 简化复杂随机分配
我衷心感谢您的合作和 Calyx 为我们计划所做的团队努力。
如果没有 Calyx 的团队专业知识,我们无法成功完成两项 Ph3的 IRT 开发。
如您所知,我们的 Ph3非常复杂,为了开发我们想要的 IRT,您需要丰富的经验、知识和系统(平台)。此外,由于 LGC 在 IRT 开发期间修订了研究方案,因此存在一些挑战和顾虑。
但是,我们严重依赖 Calyx 在 IRT 方面的专业知识,在我们的痛风计划中提供这两个复杂的试验。Calyx 就如何克服我们面临的一些挑战提出了建议,并得出了完全满足我们需求的解决方案。
我在制药行业的临床开发领域工作了 13 年。即使我的经验相对较短,我可以说,与其他 IRT 系统相比,Calyx 的平台非常有效和精致。
非常感谢。
– Younghwan Jang,
研究负责人,
LG化学有限公司
收件人: 凯理斯
发件人: ClinChoice 选择
主题: 与 Calyx 合作获得可靠的数据结果
我们选择与Calyx合作,是因为他们的科学、医疗和技术团队在提供可靠的数据结果方面拥有深度和多样性的经验。
– Tiepu Liu,总裁,
全球生物识别,
ClinChoice 选择
测试